MEU:PA:PA-Lyxor UCITS MSCI Europe D-EUR (EUR)

ETF | Others |

Last Closing

USD 187.33

Change

+2.12 (+1.14)%

Market Cap

USD 0.68B

Volume

1.76K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.17 (+0.37%)

USD 61.38B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-4.50 (-0.78%)

USD 13.43B
WRD:PA HSBC MSCI World UCITS ETF

-0.28 (-0.75%)

USD 11.05B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-3.86 (-0.93%)

USD 9.62B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-7.30 (-1.43%)

USD 8.88B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+0.19 (+0.08%)

USD 8.55B
HHH:PA HSBC S&P 500 UCITS ETF

-0.53 (-0.91%)

USD 7.68B
WLD:PA Lyxor UCITS MSCI World D-EUR

-2.66 (-0.74%)

USD 7.63B
LCWD:PA Multi Units Luxembourg - Lyxor..

-0.13 (-0.70%)

USD 6.83B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

-1.71 (-1.03%)

USD 5.48B

ETFs Containing MEU:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.51% 62% D 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.51% 62% D 56% F
Trailing 12 Months  
Capital Gain 10.17% 44% F 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.17% 43% F 60% D-
Trailing 5 Years  
Capital Gain 36.42% 58% F 70% C-
Dividend Return 1.61% 3% F 3% F
Total Return 38.03% 58% F 67% D+
Average Annual (5 Year Horizon)  
Capital Gain 11.72% 67% D+ 68% D+
Dividend Return 12.00% 64% D 65% D
Total Return 0.28% 28% F 16% F
Risk Return Profile  
Volatility (Standard Deviation) 12.43% 55% F 76% C+
Risk Adjusted Return 96.53% 80% B- 89% A-
Market Capitalization 0.68B 73% C 75% C

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.